loadpatents
name:-0.019952058792114
name:-0.016257047653198
name:-0.013458013534546
Yan; Xuelei Patent Filings

Yan; Xuelei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yan; Xuelei.The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
14.29.37
  • Yan; Xuelei - Foster City CA
  • Yan; Xuelei - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2.alpha.
Grant 11,407,712 - Beatty , et al. August 9, 2
2022-08-09
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
Grant 11,407,721 - Bartberger , et al. August 9, 2
2022-08-09
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Compounds that inhibit MCL-1 protein
Grant 11,306,107 - Brown , et al. April 19, 2
2022-04-19
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
Grant 11,274,105 - Rescourio , et al. March 15, 2
2022-03-15
Inhibitors of glucocorticoid receptor
Grant 11,208,432 - Sun , et al. December 28, 2
2021-12-28
Inhibitors Of Glucocorticoid Receptor
App 20210395295 - SUN; Daqing ;   et al.
2021-12-23
Inhibitors Of Glucocorticoid Receptor
App 20210379084 - SUN; Daqing ;   et al.
2021-12-09
Cd73 Inhibitors
App 20210346353 - BEATTY; Joel ;   et al.
2021-11-11
Tetralin And Tetrahydroquinoline Compounds As Inhibitors Of Hif-2alpha
App 20210317079 - BEATTY; Joel Worley ;   et al.
2021-10-14
Inhibitors of glucocorticoid receptor
Grant 11,124,537 - Sun , et al. September 21, 2
2021-09-21
Inhibitors of glucocorticoid receptor
Grant 11,110,103 - Sun , et al. September 7, 2
2021-09-07
Compounds That Inhibit Mcl-1 Protein
App 20210230189 - BROWN; Sean P. ;   et al.
2021-07-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
Alpha-hydroxy Phenylacetic Acid Pharmacophore Or Bioisostere Mcl-1 Protein Antagonists
App 20210047344 - RESCOURIO; Gwenaella ;   et al.
2021-02-18
Inhibitors Of Glucocorticoid Receptor
App 20210023095 - SUN; Daqing ;   et al.
2021-01-28
Inhibitors Of Glucocorticoid Receptor
App 20210017220 - SUN; Daqing ;   et al.
2021-01-21
Inhibitors Of Glucocorticoid Receptor
App 20210017219 - SUN; Daqing ;   et al.
2021-01-21
Inhibitors Of Glucocorticoid Receptor
App 20210002324 - SUN; Daqing ;   et al.
2021-01-07
Inhibitors of glucocorticoid receptor
Grant 10,836,789 - Sun , et al. November 17, 2
2020-11-17
Inhibitors Of Glucocorticoid Receptor
App 20200291058 - SUN; Daqing ;   et al.
2020-09-17
Inhibitors of glucocorticoid receptor
Grant 10,723,759 - Sun , et al.
2020-07-28
Inhibitors Of Glucocorticoid Receptor
App 20200055892 - SUN; Daqing ;   et al.
2020-02-20
Inhibitors of glucocorticoid receptor
Grant 10,472,387 - Sun , et al. Nov
2019-11-12
Inhibitors Of Glucocorticoid Receptor
App 20190218246 - SUN; Daqing ;   et al.
2019-07-18
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20180354918 - BARTBERGER; Michael D. ;   et al.
2018-12-13
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,376,425 - Bartberger , et al. June 28, 2
2016-06-28
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20160002185 - BARTBERGER; Michael D. ;   et al.
2016-01-07
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140235629 - Bartberger; Michael D. ;   et al.
2014-08-21
Benzamide derivatives and uses related thereto
Grant 8,772,296 - Powers , et al. July 8, 2
2014-07-08
Tricyclic inhibitors of hydroxysteroid dehydrogenases
Grant 8,765,788 - Powers , et al. July 1, 2
2014-07-01
Benzamide derivatives and uses related thereto
Grant 8,637,576 - Powers , et al. January 28, 2
2014-01-28
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140011796 - BARTBERGER; Michael David ;   et al.
2014-01-09
Diaza heterocyclic amide compounds and their uses
Grant 8,138,190 - Powers , et al. March 20, 2
2012-03-20
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20110319378 - BARTBERGER; Michael David ;   et al.
2011-12-29
Arylsulfonamides and uses related thereto
Grant 7,834,047 - Powers , et al. November 16, 2
2010-11-16
Tricyclic Inhibitors Of Hydroxysteroid Dehydrogenases
App 20100280073 - Powers; Jay P. ;   et al.
2010-11-04
Diaza heterocyclic sulfonamide derivatives and their uses
Grant 7,825,122 - Powers , et al. November 2, 2
2010-11-02
Arylsulfones and uses related thereto
Grant 7,754,890 - Fan , et al. July 13, 2
2010-07-13
Benzamide Derivatives And Uses Related Thereto
App 20100069447 - POWERS; Jay P. ;   et al.
2010-03-18
Benzamide derivatives and uses related thereto
Grant 7,659,287 - Powers , et al. February 9, 2
2010-02-09
Benzamide derivatives and uses related thereto
Grant 7,605,289 - Powers , et al. October 20, 2
2009-10-20
Diaza Heterocyclic Amide Compounds And Their Uses
App 20090176768 - POWERS; JAY P. ;   et al.
2009-07-09
Diaza heterocyclic amide compounds and their uses
Grant 7,524,848 - Powers , et al. April 28, 2
2009-04-28
Arylsulfonamides And Uses Related Thereto
App 20090075975 - DeGraffenreid; Michael R. ;   et al.
2009-03-19
Arylsulfonamides and uses related thereto
Grant 7,495,012 - DeGraffenreid , et al. February 24, 2
2009-02-24
Arylsulfones And Uses Related Thereto
App 20080269283 - Fan; Pingchen ;   et al.
2008-10-30
Arylsulfones and uses related thereto
Grant 7,402,704 - Fan , et al. July 22, 2
2008-07-22
Aryl sulfonamide compounds and uses related thereto
Grant 7,365,075 - DeGraffenreid , et al. April 29, 2
2008-04-29
Benzamide derivatives and uses related thereto
App 20070299111 - Powers; Jay P. ;   et al.
2007-12-27
Benzamide derivatives and uses related thereto
App 20070299080 - Powers; Jay P. ;   et al.
2007-12-27
Diaza heterocyclic amide compounds and their uses
App 20070249626 - Powers; Jay P. ;   et al.
2007-10-25
Diaza heterocyclic sulfonamide derivatives and their uses
App 20070173494 - Powers; Jay P. ;   et al.
2007-07-26
Benzamide derivatives and uses related thereto
App 20060293392 - Powers; Jay P. ;   et al.
2006-12-28
Arylsulfonamides and uses related thereto
App 20050288271 - DeGraffenreid, Michael R. ;   et al.
2005-12-29
Aryl sulfonamide compounds and uses related thereto
App 20050277649 - DeGraffenreid, Michael R. ;   et al.
2005-12-15
Arylsulfones and uses related thereto
App 20050277665 - Fan, Pingchen ;   et al.
2005-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed